UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Risk of Bias in Trial-Based Economic Evaluations

Value in health, 2014-11, Vol.17 (7), p.A442-A442

2014

Volltextzugriff (PDF)

PUK18 Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Non-Diabetic Advanced Renal Disease – A Dutch Perspective

Value in health, 2012-11, Vol.15 (7), p.A458-A458

2012

Volltextzugriff (PDF)

Identifying the Broader Value of Vaccines in Low and Middle Income Countries

Value in health, 2014-11, Vol.17 (7), p.A548-A548

2014

Volltextzugriff (PDF)

Cost-Effectiveness of Medication Adherence Enhancing Interventions: A Systematic Review

Value in health, 2013-11, Vol.16 (7), p.A335-A335

2013

Volltextzugriff (PDF)

Side-Effects of Antiepileptic Drugs: The Economic Burden

Value in health, 2013-11, Vol.16 (7), p.A622-A622

2013

Volltextzugriff (PDF)

(Cost-) Effectiveness of A Multi-Component Intervention for Adults With Epilepsy: Study Protocol of A Dutch Randomized Controlled Trial

Value in health, 2014-11, Vol.17 (7), p.A582-A583

2014

Volltextzugriff (PDF)

From Clinically Relevant Outcome Measures To Quality of Life in Epilepsy

Value in health, 2014-11, Vol.17 (7), p.A573-A573

2014

Volltextzugriff (PDF)

Eliciting Patients’ Preferences for Epilepsy Diagnostics: A Discrete Choice Experiment

Value in health, 2013-11, Vol.16 (7), p.A626-A626

2013

Volltextzugriff (PDF)

PHP227 - Risk of Bias in Trial-Based Economic Evaluations

Value in health, 2014-11, Vol.17 (7), p.A442-A442

2014

Volltextzugriff (PDF)

PP060-SUN COST-EFFECTIVENESS OF NUTRITIONAL INTERVENTION IN HIP FRACTURE PATIENTS: A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL (RCT)

Clinical nutrition. Supplements, 2012-09, Vol.7 (1), p.49-49

2012

Volltextzugriff (PDF)

PSY72 - AN EUROPEAN OVERVIEW OF THE FUTURE CHANGES IN EVIDENCE REQUIREMENTS FOR THE REIMBURSEMENT OF ORPHAN DRUGS-A STAKEHOLDER ANALYSIS

Value in health, 2014-05, Vol.17 (3), p.A236-A236

2014

Volltextzugriff (PDF)

AN EUROPEAN OVERVIEW OF THE FUTURE CHANGES IN EVIDENCE REQUIREMENTS FOR THE REIMBURSEMENT OF ORPHAN DRUGS-A STAKEHOLDER ANALYSIS

Value in health, 2014-05, Vol.17 (3), p.A236

2014

Volltextzugriff (PDF)

PHP14 - Divergent Evidence Requirements Comparing The Authorization And Reimbursement Processes Of High-Risk Medical Devices – The European Situation

Value in health, 2014-05, Vol.17 (3), p.A12-A12

2014

Volltextzugriff (PDF)

AN EUROPEAN OVERVIEW OF THE FUTURE CHANGES IN EVIDENCE REQUIREMENTS FOR THE REIMBURSEMENT OF ORPHAN DRUGS-A STAKEHOLDER ANALYSIS

Value in health, 2014, Vol.17 (3), p.A236-A236

2014

Volltextzugriff (PDF)

A best-worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment

Journal of medical economics, 2018-05, Vol.21 (5), p.1-473

2018

Volltextzugriff (PDF)

PRM31 - Identifying the Broader Value of Vaccines in Low and Middle Income Countries

Value in health, 2014-11, Vol.17 (7), p.A548-A548

2014

Volltextzugriff (PDF)

PRM171 - From Clinically Relevant Outcome Measures To Quality of Life in Epilepsy

Value in health, 2014-11, Vol.17 (7), p.A573-A573

2014

Volltextzugriff (PDF)

PRM225 - (Cost-) Effectiveness of A Multi-Component Intervention for Adults With Epilepsy: Study Protocol of A Dutch Randomized Controlled Trial

Value in health, 2014-11, Vol.17 (7), p.A582-A583

2014

Volltextzugriff (PDF)

Divergent Evidence Requirements Comparing The Authorization And Reimbursement Processes Of High-Risk Medical Devices – The European Situation

Value in health, 2014-05, Vol.17 (3), p.A12-A12

2014

Volltextzugriff (PDF)

PND24 - Side-Effects of Antiepileptic Drugs: The Economic Burden

Value in health, 2013-11, Vol.16 (7), p.A622-A622

2013

Volltextzugriff (PDF)

PIH33 - Cost-Effectiveness of Medication Adherence Enhancing Interventions: A Systematic Review

Value in health, 2013-11, Vol.16 (7), p.A335-A335

2013

Volltextzugriff (PDF)

PND44 - Eliciting Patients’ Preferences for Epilepsy Diagnostics: A Discrete Choice Experiment

Value in health, 2013-11, Vol.16 (7), p.A626-A626

2013

Volltextzugriff (PDF)

CLEAN beamforming for the enhanced detection of multiple infrasonic sources

Geophysical journal international, 2020-04, Vol.221 (1), p.305-317

2020

Volltextzugriff (PDF)

A Bird’s‐Eye View on Ambient Infrasonic Soundscapes

Geophysical research letters, 2021-09, Vol.48 (17), p.n/a

2021

Volltextzugriff (PDF)

Seismoacoustic Coupled Signals From Earthquakes in Central Italy: Epicentral and Secondary Sources of Infrasound

Geophysical research letters, 2018-01, Vol.45 (1), p.427-435

2018

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(51)
Tagungsberichte
(4)

Sprache

Englisch
(55)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk of Bias in Trial-Based Economic Evaluations

PUK18 Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Non-Diabetic Advanced Renal Disease – A Dutch Perspective

Identifying the Broader Value of Vaccines in Low and Middle Income Countries

Cost-Effectiveness of Medication Adherence Enhancing Interventions: A Systematic Review

Side-Effects of Antiepileptic Drugs: The Economic Burden

(Cost-) Effectiveness of A Multi-Component Intervention for Adults With Epilepsy: Study Protocol of A Dutch Randomized Controlled Trial

From Clinically Relevant Outcome Measures To Quality of Life in Epilepsy

Eliciting Patients’ Preferences for Epilepsy Diagnostics: A Discrete Choice Experiment

PHP227 - Risk of Bias in Trial-Based Economic Evaluations

PP060-SUN COST-EFFECTIVENESS OF NUTRITIONAL INTERVENTION IN HIP FRACTURE PATIENTS: A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL (RCT)

PSY72 - AN EUROPEAN OVERVIEW OF THE FUTURE CHANGES IN EVIDENCE REQUIREMENTS FOR THE REIMBURSEMENT OF ORPHAN DRUGS-A STAKEHOLDER ANALYSIS

AN EUROPEAN OVERVIEW OF THE FUTURE CHANGES IN EVIDENCE REQUIREMENTS FOR THE REIMBURSEMENT OF ORPHAN DRUGS-A STAKEHOLDER ANALYSIS

PHP14 - Divergent Evidence Requirements Comparing The Authorization And Reimbursement Processes Of High-Risk Medical Devices – The European Situation

AN EUROPEAN OVERVIEW OF THE FUTURE CHANGES IN EVIDENCE REQUIREMENTS FOR THE REIMBURSEMENT OF ORPHAN DRUGS-A STAKEHOLDER ANALYSIS

A best-worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment

PRM31 - Identifying the Broader Value of Vaccines in Low and Middle Income Countries

PRM171 - From Clinically Relevant Outcome Measures To Quality of Life in Epilepsy

PRM225 - (Cost-) Effectiveness of A Multi-Component Intervention for Adults With Epilepsy: Study Protocol of A Dutch Randomized Controlled Trial

Divergent Evidence Requirements Comparing The Authorization And Reimbursement Processes Of High-Risk Medical Devices – The European Situation

PND24 - Side-Effects of Antiepileptic Drugs: The Economic Burden

PIH33 - Cost-Effectiveness of Medication Adherence Enhancing Interventions: A Systematic Review

PND44 - Eliciting Patients’ Preferences for Epilepsy Diagnostics: A Discrete Choice Experiment

CLEAN beamforming for the enhanced detection of multiple infrasonic sources

A Bird’s‐Eye View on Ambient Infrasonic Soundscapes

Seismoacoustic Coupled Signals From Earthquakes in Central Italy: Epicentral and Secondary Sources of Infrasound

Suchergebnisse filtern